Litcius/Paper detail

Neoadjuvant or Adjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer: Which Is Preferred?

Eileen M. O’Reilly, Cristina R. Ferrone

2020Journal of Clinical Oncology29 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePancreatic cancerNeoadjuvant therapyAdjuvantAdjuvant therapyOncologyInternal medicineCancerBreast cancerPancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsRenal cell carcinoma treatment